Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 3Colorectal Neoplasms 2Recurrence 1Neoplasms 1Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 1Hepatic Veno-Occlusive Disease 1Disease 1Chemical and Drug Induced Liver Injury 1Breast Neoplasms 1Agnosia 1Adenoma 1

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × S-Adenosylmethionine × Clear all
NCT05701553 2023-02-02

Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma

Shanghai Zhongshan Hospital

Unknown
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03178929 2017-06-07

Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma

Beijing Insight Science & Technology Co. Ltd.

Phase NA Unknown
207 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02586285 2016-04-01

Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma

Eastern Hepatobiliary Surgery Hospital

Phase 1 Unknown
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡